Insights on the left ventricular thrombus in patients with ischemic dilated cardiomyopathy

Abstract

Background

Left ventricular thrombus (LVT) formation represents a common complication of dilated cardiomyopathy (DCM). LVT is usually underestimated with transthoracic echocardiography (TTE) while cardiac magnetic resonance imaging (CMRI) is promising as an alternative imaging modality for cardiac thrombus detection. The study aims to compare TTE and CMRI in their ability to detect LVT, also, to assess the clinical and imaging parameters to determine variables that may predispose for thrombus formation. The study population includes seventy-six patients with ischemic DCM. They were divided into 2 groups based on the presence of LVT as detected by delayed-enhancement CMRI (DE-CMRI) [Group A included 20 patients with a LVT and Group B included 56 patients without].

Results

All of the current study population had ischemic DCM with left ventricular ejection fraction (LVEF) < 50%. DE-CMR detected thrombus in 20 cases of the studied population that represented group A. From group A, conventional TTE detected LVT only in 8 and cine-CMR detected 13 cases out of the out of 20 cases. The ejection fraction of the left ventricle as measured by functional CMRI was significantly lower in group A (P = 0.045). Interestingly, the myocardial scarring in group A was seen significantly more extensive than in group B (the P value is < 0.00001), paralleling the increased prevalence of thrombus.

Conclusions

DE-CMRI provides superiority for the detection of LVT compared with standard TTE or cine-CMRI and the amount of myocardial scarring detected by DE-CMRI can be considered an independent marker for thrombus presence.

Background

Patients with dilated cardiomyopathy (DCM) are at increased short and long term risks for thromboembolic events due to left ventricular thrombus (LVT) formation. Thrombosis in the cardiac cavity is associated with a reduction of the left ventricular ejection fraction (EF) and related to kinetic disorders of the infarcted and peri-infarction areas. Early detection of LVT allows for the early initiation of anticoagulation therapy to reduce the likelihood of embolization [1]. Transthoracic echocardiography (TTE) is the first choice diagnostic tool in such patients. However, thrombus formation is usually underestimated with echocardiography because it is difficult to distinguish normal myocardium from thin mural thrombi [2].

One of the diagnostic tools that provide high contrast resolution images of the anatomy of the LVT is cardiovascular magnetic resonance imaging (CMRI). Cine-CMRI (CMRI without a contrast agent such as gadolinium) seems to be less suitable for LVT detection [3]. Delayed-enhancement CMRI (DE-CMRI) using gadolinium contrast has been well validated as a mean of characterizing viable and infarcted myocardium based on contrast uptake patterns [4]. DE-CMR differentiates thrombus from the surrounding myocardium based on tissue characteristics as thrombus is avascular and thus characterized by an absence of contrast uptake [5].

The current study aimed to zoom on LVT in patients with ischemic DCM from many aspects. Firstly, by determining the clinical and imaging predictors for LVT formation in patients with DCM. Secondly, by assessing the ability of conventional echo and cine-CMRI in the detection of thrombus compared to the gold standard DE-CMRI.

Materials and methods

Study population

This study is a retrospective, single-centre observational study. The study population consisted of 76 consecutive patients with systolic dysfunction of a clinical outpatient facility of a private hospital, between July 2018 and July 2020. Those patients were referred to the CMRI unit for evaluation of myocardial viability. Medical history was taken to assess potential predictors of the presence of LVT; including cardiac risk factors, medication regimen, and information regarding prior myocardial infarction. We included only patients with ischemic dilated cardiomyopathy. We excluded patients with dilated cardiomyopathy due to causes other than ischemia, those with contraindications for gadolinium administration or with uncompleted clinical records. The studied patients were divided, according to the presence or absence of thrombi as detected by DE-CMRI, into two groups of patients (Group A with a left ventricular thrombus and Group B without). The comparison was made between the two groups regarding age, gender, presence of mitral regurgitation, left ventricular ejection fraction, and apical wall motion abnormality. Using DE-CMRI as a reference standard, a comparison was made between standard TTE and cine-CMRI regarding their ability to detect LVT in group A.

Two-dimensional and doppler echocardiography

Echocardiographic examinations were performed using a Phillips machine with standard views and techniques. Two-dimensional (2D) images were obtained with the use of a 3.5 MHz transducer. Variable gain and depth settings were used to optimize epicardial, endocardial and thrombus margin definition. The images were obtained with the patient in the left lateral position at the end-expiration.

The echocardiographic definition of a thrombus was a consistent mass of refractile echoes that had well-defined margins adjacent to an area of the LV wall which is hypokinetic or akinetic, projected into the left ventricular cavity, easily distinguishable from the endocardium and the other intra-cardiac structures such as anomalous left ventricular chords or trabeculations, and seen in more than one view and visible throughout the systole and diastole [6]. The maximal thrombus size was measured perpendicular to the myocardium from the endocardial border extending to the innermost border of the thrombus-blood interface when viewed using apical views.

Left ventricular dimensions were determined by the leading-edge to edge method and the determination of left ventricular ejection fraction (LVEF) was calculated by using the biplane modified Simpson's method. Dilated cardiomyopathy was diagnosed, in the presence of LVEF < 50% and LV end-diastolic diameter (LVEDd) of > 56 mm [7].

Wall motion abnormality at the apex (which was the site of thrombus in all of our cases), as determined by 2D imaging, was defined as a lack of wall motion (akinesia) or a paradoxical expansion (dyskinesia) observed during systole (Fig. 1) [8].

Fig. 1

Apical four-chamber transthoracic echocardiographic appearance of a mobile, protruding thrombus (yellow arrows; in diastole and systole) in the left ventricular apex in a patient with dilated cardiomyopathy with apical akinesia. This thrombus appears more echo dense than the surrounding myocardium. LV left ventricle, LA left atrium

Mitral regurgitation, as determined by Doppler colour flow imaging, was semi-quantitative by relating the area of the regurgitant jet to the left atrial area, with a ratio of < 20% being mild mitral regurgitation (Grade 1), 20 to 40% being moderate mitral regurgitation (Grade 2) and a ratio of > 40% being severe mitral regurgitation (Grade 3) [9].

Cardiac magnetic resonance imaging

All CMR examinations were performed on a 1.5-T MRI system (Avanto, Siemens Healthcare, Erlangen, Germany) equipped with a 32-element cardiac coil array. All scans were ECG-gated for synchronization with the cardiac cycle and performed in end-expiration and following a local standard protocol that included the following sequences:

• 1. Three localizing single-shot steady-state sequences in the three orthogonal planes, followed by axial, sagittal, and coronal multi-slice half-Fourier-acquired single-shot turbo spin-echo (HASTE).

• 2. Cine sequences: Steady-state free precession (SSFP)-oriented 2-chamber vertical long-axis, 4-chamber horizontal long-axis, 3-chamber, and short-axis views for studying the kinetics of the right and left ventricles. Acquisition time, 7–12 s each slice; matrix, 192 × 192; flip angle, 180°; echo time (ET), 1.69 ms.

• 3. Phase-contrast sequence to quantify the amount and severity of the mitral regurgitation in suspected cases. This sequence was planned with one slice perpendicular to the mitral valve using four chambers and two-chamber views, velocity encoding (VENC) = 150 cm/s for normal flow, retrospective gating, and short TE for optimal flow sensitivity.

• 4. Phase-sensitive inversion recovery (PSIR) sequences in free-breathing for studying early gadolinium enhancement (EGE) 1–3 min after intravenous administration of gadolinium (0.1–0.2 mmol/kg) with longer inversion times than those for LGE around (450–500 ms) for diagnosis of intracavitary thrombi, then late gadolinium enhancement (LGE) performed 10–15 min to detect myocardial infarction/ scarring; inversion time (300–400 ms). FOV, 244 × 300 mm²; matrix, 156 × 256.

Quantitative evaluation for LVEF was carried out using Siemens imaging software Syngo. Systolic dysfunction was defined as a LVEF below 56% measured quantitatively on short-axis cine-CMR [10]. The presence and transmural extent of the enhancement were reported and the number of enhancing segments was counted.

Statistical methods

Normally distributed continuous data were expressed as mean ± SD and between-group comparisons were performed using 2-sample t-tests. Chi-square tests were used to compare discrete data between groups; in those cases, in which the expected cell count was < 5, the Fisher exact test was used. We analyzed the value of clinical variables for predicting the presence of thrombus by DE-CMR. All clinical variables were considered and the incremental value of adding LVEF by cine-CMR and myocardial scarring by DE-CMR was assessed using likelihood ratio tests. All statistical tests were 2-tailed; values of p < 0.05 were regarded as significant.

Results

The study population was composed of 76 patients with ischemic DCM. The mean age of the studied patients was 54.1 ± 9.5 years. Male patients represented 86.8% of all the studied patients. The patients’ population were divided into two groups based on the presence of LVT; Group A with thrombus (n = 20 [26.3%]) and Group B without thrombus (n = 56 [73.7%]).

Clinical characteristics between the 2 groups of patients did not differ concerning the age, gender, and risk factors for coronary artery disease (Table 1). There was also no statistically significant difference between the two groups regarding the prevalence of functional mitral regurgitation (MR) which was noted by TTE in 8 patients out of 20 (40%) in group A and 34 patients out of 56 (44.7%) in group B.

Table 1 : Baseline clinical characteristics of the whole study group and patients with and without LV Thrombus (Group A and B; respectively)

The apex of the left ventricle was involved by the thrombus in all of the studied patients. All studied patients had akinetic or dyskinetic apex that was evaluated by TTE and Cine-CMRI and showed no statistically significant difference between group A and group B.

Upon comparing the two groups of patients concerning their LVEF as determined by Cine-CMR and TTE, there was evidence of advanced systolic dysfunction in both groups. The mean difference between the two groups was 6.2% using both Cine-CMRI and echocardiography; which is statically significant (P = 0.03 and 0.002; for both techniques respectively) (Table 2).

Table 2 Comparison of left ventricular ejection fraction between group A and group B

Interestingly, the myocardial scarring as detected by DE-CMRI, in the form of transmural enhancement or sub-endocardial enhancement more than 50% [11, 12], in group A was seen significantly more extensive than in group B according to the number of left ventricular segments affected (The t value was 6.9 and the P value was < 0.00001). The mean number of segments affected was higher in group A than in group B (7.3 ± 3.3 and 4.2 ± 2.1), paralleling the increased prevalence of thrombus.

Thrombi were detected by DE-CMRI in twenty cases that represented 26.3% of our studied population; out of them, only 8 cases (40%) were detected by conventional echocardiography while 12 cases were missed (Fig. 2). TTE also detected LVT in 2 cases in group B which were considered as a false positive result. Cine-CMRI detected intracardiac thrombi in 13 out of these 20 cases with a prevalence of 65% which was not statistically better than conventional TTE (P = 0.02). Comparing with DE-CMRI, detection of LVT in both TTE and cine-CMRI was significantly less (P = 0 and 0.008; respectively) (Fig. 3).

Fig. 2

Illustrative example of Comparing echocardiography and cine-CMRI by DE-CMRI in diagnosis of LVT. In this case, while the standard apical four-chamber Echocardiographic view (e) was inconclusive, cine-CMR imaging provided a better appreciation of the thrombus, four chamber view (a) and (Additional file 1: Movie 1) and two-chambers long-axis view (c) and (Additional file 2: Movie 2). Appearance of the same thrombus more appreciated using DE-CMRI four chamber view (b) and two-chamber long axis view (d)

Fig. 3

69-year male with CAD. Apical dilatation is appreciated in cine 2 chambers long axis view (a) and (Additional file 3: Movie 3) and three-chambers view (b) and (Additional file 4: Movie 4) while the thrombus couldn’t be visualized. Thrombus can be easily recognized in delayed post-contrast views on top of transmural enhancement of the underlying myocardium; four-chambers (c) and two-chambers long-axis (d)

In the current study, all the thrombi were involving at least the ventricular apex, adherent to the wall with an average size of 1.9 ± 0.14 cm as detected by DE-CMRI and of 2.5 + 1.14 cm as detected by conventional echocardiography (Fig. 4).

Fig. 4

a Long axis 2 chambers view (white blood) shows an isointense intraluminal lesion with underlying apical akinesia in cine sequence (Additional file 5: Movie 5). Delayed post contrast sequences in short axis (b), 4 chambers view (c) and 2 chambers long axis view (d) show nulled myocardial signal with transmural mid and apical septal enhancement reflecting non-viable myocardium and intraluminal thrombus

Discussion

Ventricular thrombus formation in DCM reflects the presence of factors that represent Virchow's triad in the ventricle including local myocardial injury, reduced wall motion, and slow flow of the blood [13]. The clinical importance of LVT is that it carries the risk of embolic events. The incidence of LVT in the current study was 28.3%, which was higher than the incidence in other prospective studies (0.7–8%) [14, 15]. This can be explained by that, in the current study, we made a zoom on LVT in patients with ischemic DCM who were suspected to have thrombus.

In the current study, there was no significant difference in clinical variables between the two groups of studied patients regarding hypertension, dyslipidemia, smoking and diabetes mellitus and these results matched with Jiang and others in 2015 [14].

In the current study, all patients were on beta-blockers. In the literature, there is a controversy regarding the negative influence of beta-blockers in the occurrence of LVT in patients with DCM. Many studies reported a higher frequency of thrombus development in those patients when treated with beta-blockers and could be explained by the negative inotropic action of these drugs and thus increased blood stasis that contributes as one of the three components of Virchow's triad facilities the formation of LVT. Turpie et al. in 1989; reported an increased occurrence of thrombus in patients with anterior myocardial infarction after oral b-blocker therapy [16]. Un matching results were described in the GISSI-2 study that observed the same rate of LVT in patients with or without atenolol [17].

Secondary mitral regurgitation (MR) is an important issue in DCM patients. It is not due to a disease of the leaflets but to the symmetrical or asymmetrical dilation of the left ventricle [18]. It was reported that MR prevents thrombus formation in patients with DCM and this protective effect can be explained by increasing early diastolic flow velocities at the mitral annulus level and along the entire length of the LV, protecting the LV cavity from a slow blood flow pattern which is thrombogenic [19]. In the currently studied patients, no statistically significant difference was found between patients with or without LVT in presence of functional MR. MR was detected in 40% of group A and 44.7% of group B, which is consistent with the study of Garg et al. in 2019 [19], suggesting that this is not a major discriminatory variable in the formation of thrombus. However, Maze and others in 1989 noted a higher prevalence of MR in the no thrombus group [20]. Therefore, whether MR in patients with DCM is capable of decreasing blood stasis and LVT formation needs to be furtherly evaluated.

LVT are typically located in areas of reduced wall motion and adjacent to scars. The wall motion abnormality at the apex, which was the site of the thrombus in all cases in the current study, was not significantly different between groups A and B. All studied patients had akinetic or dyskinetic apex. The current study results were concordant with Maze et al., as they stated that no significant statistical difference between the thrombus and non-thrombus groups concerning the motion abnormality at the apex [20].

The presence of LVT is significantly related to the severity of LV functional impairment in patients with DCM [21]. Blood stagnation in the weak non-contractile segment of the ventricle plays a major role in the formation of thrombi [22]. In the current study, the two groups of patients showed evidence of advanced systolic dysfunction but more in group A with thrombi than in group B without. Several studies have shown that increased left ventricular internal diastolic diameters and low EF are independent predictors of LVT formation [6, 23]. Timely identification of LVT in patients with reduced EF is necessary to avoid delays in treatment with systemic anticoagulation. This identification is pretty important in patients with LV-EF ≤ 30% and sinus rhythm as prophylactic systemic anticoagulation is not supported in this group of patients relative to the increased risk of bleeding [24]. Therefore, advanced systolic dysfunction per se could not be used as an independent factor and a rationale for early treatment with prophylactic anticoagulant therapy to reduce the likelihood of embolization among the patients with ischemic DCM as the risk of bleeding also increased.

It has been noticed that the increase in the prevalence of LVT was paralleled by an increase in the scar burden. In the current study, the myocardial scarring as detected by DE-CMRI was seen significantly more extensive in patients with LVT than in patients without thrombus which matched with Kaolawanich and Boonyasirinant in 2019 as they stated that extensive apical scarring was found more significant in patients with thrombus than those without thrombus (63.3% vs 23.3%; P value < 0.0001) [25]. Therefore, apical scarring can be considered as additional evidence demonstrating the significant value of apical changes and the amount of myocardial scarring as independent markers for thrombus formation.

In the current study, the thrombus prevalence was often higher among patients with extensive myocardial scarring. This might confirm the concept of “the independent value of myocardial scarring” that might in part explain the marked difference in thrombus prevalence regardless of the severity of systolic dysfunction. In 2008 Weinsaft and others identified a low LVEF and myocardial scarring as independent risk factors of LVT formation [26].

Echocardiography is a widely employed modality in the diagnosis of LVT because it is readily available, safe, relatively cheap, and convenient but it is operator-dependent. In a setting of adequate imaging of the heart, TTE provides excellent specificity (85–90%) and sensitivity (95%) in detecting LVT [24]. In the current study, standard TTE was the first-line imaging modality used to screen for LVT. However, it was a challenge because TTE detects thrombus based on anatomical characteristics thus having a high ability to detect large and protuberant thrombi but limited in small and mural thrombi.

CMRI for detection of LVT in DCM is potentially more advantageous, compared with standard TTE not only in providing better morphological definition (anatomical characteristics) by providing cine imaging but also can characterize and differentiate LVT from other structures after contrast administration [27]. DE-CMR differentiates thrombus from surrounding myocardium as thrombus is avascular and thus characterized by an absence of contrast uptake. On the other hand, cine-CMRI without a contrast agent may be relatively insensitive for thrombus detection because thrombus may be camouflaged with the surrounding myocardium [4].

From the studied patients, routine TTE failed to detect thrombus in 12 out of 20 cases (60%). These results are consistent with Mollet et al. in 2002 who reported that among 12 patients with thrombus detected by CMRI, 58% (7 out of 12) were not detected by echocardiography [28]. Also, the current results matched the other studies that compared DE-CMRI and TTE and stated that DE-CMRI is superior for the detection of LVT [29, 30]. The limitations of TTE in detecting LVT were probably due to intra and inter-observer variation for detection of LVT that are lower for CMRI in comparison to TTE. One of the other factors that decreased detection of LVT in TTE is a poor acoustic window and it may be difficult to fully interrogate a very dilated ventricle if acoustic windows are limited. Broncano et al. in 2020 stated that cardiac MRI is not limited by acoustic windows as is TTE [31].

All of LVT in the current study patients involved the apical segments and it is well known that LVT is most frequently seen in the left ventricular apex as a common location in patients with ischemic as well as non-ischemic DCM [32].

Taken together, DE-CMR is usually interpreted in conjunction with cine-CMR, therefore the current study cannot permit conclusions to be made regarding the utility of DE-CMR alone for LVT detection. We used DE-CMRI as a gold standard in the detection of LVT as it is better than standard echocardiography and cine-CMRI alone. In the current study, cine-CMRI detected LVT in 13 out of 20 cases detected by DE-CMRI, with a prevalence of 65% which was not statistically significant when compared with TTE in the detection of LVT in the same group. These results matched with Weinsaft and others in 2011 who stated that DE-CMRI was the most accurate modality for detection of LVT, followed by cine-CMRI, and finally standard TTE [33].

Finally, it is very important to avoid false-positive results occasioned by endocardial elastosis, trabeculae, false tendons near-field clutter, lipomatous metaplasia, and artefacts among others [7]. In the current study, DE-CMRI did not detect LVT in cases of Group B, however, LVT was detected by TTE in two cases of this group, which may be false-positive results.

The present study has some limitations. Firstly, it was a small single-centre study and further studies which include more patients or multicenter studies are necessary for the validation of our results. Secondly, being a retrospective study, the outcome of LVT in the studied patients could not be evaluated. Thirdly, assessment of other clinical risk factors associated with LVT in patients with DCM has not been done, making the assessment of causality rather inconclusive.

Conclusions

Multiple imaging modalities are required for detailed and comprehensive evaluations of patients with DCM and suspected LVT. TTE is the imaging modality of choice in those patients as it is cheap, more available and disadvantage of the contrast and possibility of nephrogenic systemic fibrosis, especially in repeated times [33]. However, our study showed that DE-CMRI added value towards competing TTE and Cine-CMRI modalities relies on its excellent tissue characterization of LVT with potentially relevant therapeutic and prognostic implications. DE-CMRI provided superiority for detection of the amount of myocardial scarring that can be considered as an independent marker for thrombus formation.

Developing strategies based on CMRI for the detection of cardiac thrombi and flow stasis is of great clinical interest. Therefore, further investigations and efforts are needed to improve the evaluation of slow flow and early thrombi detection in patients with DCM and to ascertain whether DE-CMRI findings can be used to guide anticoagulant therapy and improve clinical outcomes among those population of patients at risk for LVT and related complications.